Evidence map›Paper›PMID 32599720›Full record

ArticleFoods (Basel, Switzerland)2020

Evaluation of Amyloid β

Masahiro Kuragano, Wataru Yoshinari, Xuguang Lin, Keiya Shimamori, Koji Uwai, Kiyotaka Tokuraku

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. FermentedFoods (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. Novel Analytical Methods in Food Analysis.Foods (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Masahiro KuraganoGraduate School of Engineering, Muroran Institute of Technology, Muroran 050-8585, Japan.ORCID 0000-0002-4958-1286
Wataru YoshinariGraduate School of Engineering, Muroran Institute of Technology, Muroran 050-8585, Japan.
Xuguang LinGraduate School of Engineering, Muroran Institute of Technology, Muroran 050-8585, Japan.
Keiya ShimamoriGraduate School of Engineering, Muroran Institute of Technology, Muroran 050-8585, Japan.
Koji UwaiGraduate School of Engineering, Muroran Institute of Technology, Muroran 050-8585, Japan.
Kiyotaka TokurakuGraduate School of Engineering, Muroran Institute of Technology, Muroran 050-8585, Japan.ORCID 0000-0002-7747-4808
Muroran Institute of Technology · JP

Funding

Japan Science and Technology Agency MP28116808300Japan Society for the Promotion of Science JP16H03288
6 · The paper itself

Abstract

The aggregation and accumulation of amyloid β (Aβ) in the brain is a trigger of pathogenesis for Alzheimer's disease. Previously, we developed a microliter-scale high-throughput screening (MSHTS) system for Aβ

Indexed as

Alzheimer’s diseaseAmyloid βamyloid β aggregation inhibitorquantum dotsoy sauce

Identifiers

PMID32599720
PMCPMC7353666
OpenAlexW3037342004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.